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People with Down Syndrome (DS) have a high prevalence of physical and psychiatric
comorbidities and experience early-onset dementia. With the outbreak of CoVID-19
pandemic, strict social isolation measures have been necessary to prevent the spreading
of the disease. Effects of this lockdown period on behavior, mood and cognition in people
with DS have not been assessed so far. In the present clinical study, we investigated
the impact of CoVID-19-related lockdown on psychosocial, cognitive and functional
well-being in a sample population of 46 adults with DS. The interRAI Intellectual Disability
standardized assessment instrument, which includes measures of social withdrawal,
functional impairment, aggressive behavior and depressive symptoms, was used to
perform a three time-point evaluation (two pre-lockdown and one post-lockdown) in 37
subjects of the study sample, and a two time point evaluation (one pre- and one post-
lockdown) in 9 subjects. Two mixed linear regression models – one before and one after
the lockdown – have been fitted for each scale in order to investigate the change in the
time-dependent variation of the scores. In the pre-lockdown period, significant worsening
over time (i.e., per year) was found for the Depression Rating Scale score (β = 0.55; 95%
CI 0.34; 0.76). In the post-lockdown period, a significant worsening in social withdrawal
(β = 3.05, 95% CI 0.39; 5.70), instrumental activities of daily living (β = 1.13, 95% CI
0.08; 2.18) and depression rating (β = 1.65, 95% CI 0.33; 2.97) scales scores was
observed, as was a significant improvement in aggressive behavior (β = −1.40, 95% CI
−2.69; −0.10). Despite the undoubtful importance of the lockdown in order to reduce
the spreading of the CoVID-19 pandemic, the related social isolation measures suggest
an exacerbation of depressive symptoms and a worsening in functional status in a
sample of adults with DS. At the opposite, aggressive behavior was reduced after the
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lockdown period. This finding could be related to the increase of negative and depressive
symptoms in the study population. Studies with longer follow-up period are needed to
assess persistence of these effects.
Keywords: COVID-19, lockdown, down syndrome, functioning, well-being
INTRODUCTION
Down Syndrome (DS) is the most common genetic cause of
developmental disability and cognitive impairment, with an
incidence of about 1/800 live births (1). DS is also referred
to as a “segmental” progeroid syndrome, with selected organ
systems experiencing early aging and persons with this condition
might present patterns of co-morbidities commonly observed
in the older population (2). Moreover, people with DS start
experiencing progressive cognitive impairment early in life, with
a prevalence of dementia as high as 68–80% at the age of 65
years (3). The clinical picture of individuals with DS is often
complicated by the presence of functional deficits, behavioral
symptoms and nutritional and social problems, all of which
have increased prevalence with age (4, 5). Sociality and social
interactions are important for individuals with DS, who identify
family involvement and affection as main supporting pillars in
life (6). Interestingly, individuals with DS tend to have higher
global scores for social adaptive skills compared to adults with
other intellectual disabilities (ID) (7).
Despite the relatively high prevalence of DS in the general
population, few data are available about the impact of
Coronavirus disease-19 (COVID-19) among those with DS (8, 9).
Concerns about the COVID-19 epidemic in this population
are related to the presence of a dysfunctional immune system,
possible exacerbations of psychiatric conditions and worsening
of functional and cognitive impairment (10). With the pandemic
outbreak, several countries including Italy implemented strict
social isolation measures referred to as lockdown, to contain the
contagion (11). The Italian government issued a provision to
guarantee care to persons with disabilities during the lockdown
period. In spite of that, a large part of the social assistance
structures dedicated to people with DS and their caregivers had
to drastically reduce their activities, depriving people with DS
and their families/caregivers of effective support. This reduction
of social, recreational and work activities during the lockdown
may have impaired the physical and psychological resilience of
the general population (12) and similarly may have triggered or
exacerbated behavioral and mood changes or have worsened the
global and cognitive functioning of adults with DS. However,
no data are available yet on the effects of the lockdown in this
vulnerable population. Therefore, the aim of the present study
was to describe the impact of COVID-19-related lockdown on
psychosocial, cognitive and functional well-being in a sample
population of adults with Down syndrome.
METHODS
This clinical study included adults with DS, aged 18 years
or older, followed at the outpatient clinic of the Geriatric
Department of the Fondazione Policlinico Universitario
A. Gemelli IRCCS, Università Cattolica del Sacro Cuore
Rome, Italy since 2015 to date. Participants were referred
to the clinic by DS associations and family physician and
received a comprehensive medical assessment that included
a multidimensional evaluation with the interRAI Intellectual
Disability (InterRAI-ID) instrument (13–15).
The present study enrolled subjects with the following
characteristics: adults with confirmed genetic diagnosis of DS,
without severe intellectual disability (QI < 20) and either two
InterRAI-ID evaluations from 2015 since the beginning of
lockdown in Italy (11th of March 2020) or one InterRAI-ID
evaluation within 6-months before the lockdown. Among these
eligible participants, telephone-based interRAI-ID follow-up was
performed after the lockdown (since 15th April 2020 to 31st May
2020) to all the persons/caregivers willing to participate.
The study was approved by the Ethical Committee of the
Università Cattolica del Sacro Cuore. Informed consent was
obtained from all participants. The surrogate legal representative
was asked to get the information and give consent in those
cases where individuals were unable to make the decision
for themselves.
Psychosocial, Cognitive, and Functional
Assessment With the InterRAI-ID
Instrument
Psychosocial, cognitive and functional well-being were evaluated
through the interRAI-ID instrument, which contains over 350
data elements including socio-demographic variables, clinical
items about physical and cognitive status, functioning, behaviors,
and signs, symptoms, syndromes and treatments being provided
(15). Items are compiled by a trained assessor based on
history and basic signs and symptoms (e.g., face expressions,
disruptive behaviors, pain frequency and intensity) collected
directly from the individual being assessed, by an informant
selected among the closest relatives (parents or siblings) or long-
standing caregiver; a number of questions are asked directly
to the individual concerning his or her preferences, outlook
and well-being. Clusters of items are set up in algorithms and
scales to deliver clinically relevant triggers to inform subsequent
clinical evaluation. Such scales have proven internally consistent
and valid among adults with ID (15). Cognitive status is
evaluated through the Cognitive Performance Scale (CPS) (16)
ranging from 0 (no cognitive impairment) to 6 (severe cognitive
impairment). Functional status is evaluated through the 7-
point Activities of Daily Living Hierarchy (ADLH), used to
identify persons requiring assistance in ADLs (17), and through
the 7-point Instrumental Activities of Daily Living Hierarchy
(IADLH), used to identify those requiring assistance with IADLs
(18). The two scales ranges from 0 (independent) to 6 (totally
dependent). Depressive symptoms are assessed through the
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Depression Rating Scale (DRS), ranging from 0 to 14 with score
≥3 being indicative of depression DRS has been cross-validated
with other scales such as the Hamilton Depression Scale (19).
Aggressive behavior is assessed through the Aggressive Behavior
scale (ABS), ranging from 0 to 12. A score from 1 to 4 defines
mild/moderate aggressive behavior and scores ≥5 define severe
aggressive behavior (20). The presence of negative symptoms,
such as withdrawal from activities of interest, lack of motivation,
reduction in social interaction or anhedonia, is evaluated through
the SocialWithdrawal Scale (SOCWD). Scores range from 0 to 12
with higher scores indicating higher levels of anhedonia (21). The
presence of communication problems is evaluated through the
Communication Scale (COMM), with score from 2 to 5 defining
mild/moderate communication problems and scores from 6 to 8
defining severe communication problems (22). The PAIN scale
scores pain in a 4-point scale, ranging from 0 (no pain) to 3
(severe daily pain) based on recollection by the person or the
caregiver and is highly predictive of pain as measured by the
Visual Analog Scale (23). ADLH and IADLH are coded according
to the actual situation at the time of assessment while time
frequencies of the items in the other scales are classified as present
every day in the past 3 days, present in the past three days but
not daily, present at least once in the last 30 days, not present (or
present more than 30 days before the assessment).
Analytical Approach
Sample characteristics were reported as mean and standard
deviation (SD) or count and percentage (%). To compare the
changes in the abovementioned scales before and after the
lockdown, the follow-up time was centered around an index
date, the day when the lockdown was established in Italy (11th
March 2020). A value for each of the scales at the index date
was predicted for each individual: assuming a linear change, for
those with two available observations before the index date, we
performed intra-subject linear regressions, considering time as
predictor. Predicted values were rounded to the nearest integer.
Since in the imputation procedure the variables were treated
as continuous, the predicted values could fall outside the real
range of variation. In this case, the predicted values have been
approximated to the largest or smallest value belonging to the
range, depending on the situation. For those individuals with
only one observation preceding the lockdown, the predicted
values at the index date were set as equal to the values observed
previously (which were observed no more than 6 months
before the lockdown). With the aim to evaluate the changes
in participant’s condition during the lockdown, a sign test for
matched data was performed for all the considered scales. The
test compares the distribution of the estimated values at the
beginning of the lockdown with the distribution of the values
observed afterwards. The null hypothesis was that the median
of the estimated values at time 0 was equal to the median of
the values detected during the lockdown period. Two mixed
linear regression models – one before and one after the index
date – have been fitted for each scale in order to investigate
the change in the time-dependent variation of the variables.
All models were adjusted by age and sex and a random effect
was introduced at the intercept. A p < 0.05 was considered
TABLE 1 | Sample characteristics before the lockdown.
Mean/count (SD/%)
n = 46
Sex (female) 23 (50%)
Age (years) 40.6 (13.3)
Residential status
Living at home 37 (80.4%)
Other (Institution, group home, etc.) 9 (19.6%)
Persons with legal guardian 18 (39.1%)
Living arrangement
With parents or guardians 30 (65.2%)
With siblings 7 (15.2%)
With non-relatives 9 (19.6%)
Alcohol use (1 drink in last 14 days) 5 (10.9%)
BMI (Kg/m2) 26.0 (4.6)
Medical conditions
Language disorders 5 (10.9%)
Cognitive decline 8 (17.4%)
Depression 5 (10.9%)
Autistic spectrum disorders 1 (2.2%)
Congenital cardiopathy 12 (26.1%)
Obesity 10 (21.7%)
Blood Cells abnormalities 7 (15.2%)
Visual impairment 40 (87%)
Hypoacusis 13 (28.3%)
Thyroid diseases 23 (50.0%)
Obstructive sleep apneas 7 (15.2%)
Osteoporosis 11 (23.9%)
Psoriasis 7 (15.2%)
Musculo-skeletal disorders 9 (19.6%)
N. of drugs 2.3 (2.0)
N. of psychotropic drugs 0.5 (0.9)
Informal care (hours in last 3 days) 43.0 (30.5)
as statistically significant. Stata (StataCorp) 16.0 was used in
all analyses.
RESULTS
Since 2015, a total of 221 adult individuals with DS were
evaluated with the InterRAI-ID assessment in our clinic.
We present data about 46 eligible individuals that agreed
to participate to the telephone-based interRAI-ID follow-up
after the lockdown. Nine of them had received an evaluation
within 6 months before the lockdown and 37 had received
two from 2015 until the lockdown. The characteristics of the
study population before the lockdown are shown in Table 1.
Mean age was 40.6 ± 13.3 years, 23 subjects were female
(50%). Overall, 18 individuals (39.1%) were under the protection
of a legal guardian and 9 (19.6%) were living with non-
relative persons. On average they had received 43.0 ± 30.5 of
informal care from family members, friends or neighbors in
the 3 days before the evaluation. The most frequent medical
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conditions were visual impairment (87%), thyroid diseases
(50%), hypoacusis (23.8%) and congenital cardiopathies (26.1%).
Neuropsychiatric conditions were also prevalent: dementia was
present in 8 persons (17.4%), 5 presented depression (10.9%),
and 5 had language disorders (10.9%). One subject had autistic
spectrum disorders. The mean number of regularly used drugs
was 2.3 ± 2.0 and the mean number of psychotropic drugs
was 0.5± 0.9.
Table 2 shows the mean scores of the investigated scales and
the results of the sign test for the evaluation of changes in physical
and mental health scales before and after the lockdown. The
number of subjects that have worsened, improved or remained
constant was significantly different for the IADLH scale (p =
0.003), for the ABS (p = 0.046), for the DRS (p = 0.032) and for
the SOCWD scale (0.011).
Figure 1 and Table 3 shows the rate of change (β coefficient
and 95% C.I.) over time of physical and mental health scales
before and after the lockdown. Regarding the pre-lockdown
period, a significant worsening over time (i.e., per year) was
only found for the DRS score (β = 0.55; 95% CI 0.34; 0.76).
Regarding the post-lockdown period, significant worsening in
scores over time was found for the SOCWD scale (β =
3.05, 95% CI 0.39; 5.70), IADLH scale (β = 1.13, 95% CI
0.08; 2.18), and DRS (β = 1.65, 95% CI 0.33; 2.97), while
a significant improvement was found for ABS (β = −1.40,
95% CI −2.69; −0.10). ADLH scale, CPS, COMM scale and
PAIN scale did not show significant changes over time both
during the pre-lockdown and in the post-lockdown period
(p > 0.05 for all).
DISCUSSION
The present study shows that social isolation measures related
to COVID-19 lockdown reverberated on the functional and
psychosocial well-being of adults with DS. To our knowledge, this
FIGURE 1 | Rate of change over time of physical and mental health scales before and after the lockdown. Points represent the scores obtained by each individual in
the different evaluation events. Fit line in the pre-lockdown phase in red color; fit line in the post-lockdown phase in blue color. The fit parameters are specified in
Table 3.
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TABLE 2 | Mean scores of the scales before and after the lockdown and sign test
for the evaluation of changes in participants condition during the lockdown.
Mean score of testsa Sign test for changesb
Before After Worsening Improvement No p-value
lockdown lockdown changes
ADLH 1.3 (1.5) 1.4 (1.3) 10 5 31 0.151
IADLH 3.9 (1.3) 4.2 (1.2) 11 1 34 0.003
ABSc 1.1 (1.4) 0.8 (1.0) 3 10 32 0.046
CPS 2.6 (0.8) 2.8 (1.0) 4 0 42 0.063
COMM 2.5 (1.4) 2.5 (1.3) 5 7 34 0.387
DRS 3.5 (2.0) 3.9 (1.7) 17 7 22 0.032
PAIN 0.5 (0.6) 0.4 (0.5) 0 3 43 0.125
SOCWD 0.8 (2.1) 1.6 (2.6) 13 3 30 0.011
aMeasures before lockdown refers to the values imputed at the beginning of the lockdown,
while conditions after lockdown refers to the values observed afterwards.
bThe test compares the estimated values at the start of the lockdown with those observed
afterwards. For each scale, the number of subjects that have worsened, improved or
remained constant is reported.
cThere was no information regarding the value of the ABS variable after the lockdown for
one of the study subjects. Therefore, that individual was not taken into consideration in
the analysis of the ABS variable.
Bold values highlight parameters with statistically significant change.
SOCWD, Social withdrawal scale; ADLH, ADL hierarchy scale; IADLH, IADL hierarchy
scale; COMM, Communication Scale; ABS, Aggressive Behavior scale; DRS, Depression
Rating scale; CPS, Cognitive performance scale.
TABLE 3 | Rate of change (β and 95% C.I.) over time of physical and mental
health scales before and after the lockdown.
Functional Pre-lockdown Post-lockdown
scales change per year change per year
β 95% C.I. p-value β 95% C.I. p-value
SOCWD 0.04 −0.21; 0.30 0.742 3.05 0.39; 5.70 0.024
ADLH 0.09 −0.05; 0.25 0.208 0.23 −0.78; 1.24 0.651
IADLH −0.10 −0.23; 0.02 0.112 1.13 0.08; 2.18 0.034
COMM −0.03 −0.20; 0.14 0.759 −0.29 −1.23; 0.64 0.537
ABS 0.13 −0.03; 0.29 0.117 −1.40 −2.69; –0.10 0.034
DRS 0.55 0.34; 0.76 <0.001 1.65 0.33; 2.97 0.014
CPS −0.03 −0.16; 0.09 0.595 0.55 −0.22; 1.31 0.164
PAIN 0.04 −0.03; 0.10 0.290 −0.26 −0.57; 0.05 0.106
C.I., confidence interval.
Bold values highlight parameters with statistically significant change.
For all measures positive changes mean worsening and negative changes improvement
in scale.
is the first study describing the functional and psychosocial effects
of the lockdown during the COVID-19 pandemic in people
with DS.
Lockdown should be considered a potentially traumatic life-
stressor event (24). Findings of our study should be discussed
taking into account the adaptive behavior skills of individuals
with DS. Throughout the lifespan, individuals with DS tend
to demonstrate an adaptive behavior profile that involves
relative strengths in receptive communication skills, domestic
and community daily living skills and coping and interpersonal
relationship socialization skills. Relative difficulties were reported
in expressive and written communication (25). However, lower
daily living coping skills and overall low adaptive behavior skills
have been described for adults with DS when compared to age-
matched general population individuals (26). Similar findings
were found for elderly as compared to adult population {Cheng,
2014 #110}. In addition, in our sample, prevalence of visual
and hearing impairment was high and sensorial deprivation can
worsen adaptive behavior in adult individuals (27). But, it seems
that vision problems do not decrease adaptive behavior skills in
individuals with DS (28).
As expected from a lockdown-compliant population, our
study sample showed a significant increase in social withdrawal
scores (SOCWD) in the post-lockdown period. However, since
the scale includes also dimensions other than social interactions
indicators, the increase in SOCWD scores can also reflect an
increase in anhedonia and lack of motivation. Notably, a high
percentage of PTSD symptomatology, including anhedonia and
sleep disturbances, was found also in a study including a sample
of the general population in Italy (29). It is plausible that
individuals with DS– frequently affected by neuropsychiatric
conditions and dementia – may have been particularly prone to
present such exacerbations.
We detected an increased depression burden during the post-
lockdown period. Depressive symptoms are common among DS
adults (30) and according to the pre-lockdown observation they
appear to proceed faster than other measures. Yet, the time-
dependent change in the DRS scores during the post-lockdown
period was up to three time higher than pre-lockdown period,
suggesting that stressor events (i.e., lockdown) could severely
impact mood in individuals with DS (30). On the contrary,
aggressive behavior scores (ABS) showed a significant decrease
during post-lockdown period. A possible explanation of the
decreased aggressive behavior observed in our study is that
persons with DS are more likely to aggression toward peers
or people who are not family members (31). Hence, social
isolation could have reduced such external stimulation, resulting
in a less demanding environment. On the other hand, it is
known that catatonia and regression are frequent among young
adults with DS facing stressful events (32), and internalized
symptoms of depression emerge while externalized symptoms of
aggressiveness decrease as they age (31). Indeed, social isolation
in individuals with DS might have exacerbated or triggered
negative symptoms (i.e., withdrawal, anhedonia, depression),
while it could have mitigated aggressive behaviors.
From a functional point of view, there was a significant
increase in IADL scores in the post-lockdown period, suggesting
a decrease in independence in activities such as paying for things,
shopping, and taking public transportation. On the one hand, this
might be a consequence of the lockdown itself (compulsory stay-
at-home policies, mandating closure of non-essential businesses),
on the other hand it might have been the consequence of
the disruption to their routines resulting in difficulties to
understanding and adapting to the new requirements (such as
wearing the face mask and respecting the contingent row at
the supermarket), as has been described in the general elderly
population (33). Conversely, the post-lockdown period did not
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show significant changes in ADL scores. This finding suggests
that basic self-care activities such as dressing, washing and eating
are less likely to be impaired by such stressor event.
The management of lockdown presents a perfect storm for
mental distress for older people (34) and potentially even more
for individuals with DS. Indeed, at any age individuals with ID
present with significantly higher rates ofmental health conditions
when compared to the general population (35), and it is essential
to thoroughly investigate their experience to devise effective ways
of protecting them (10).
Limitations
The present study has some important limitations. The study
sample is small and with pre-lockdown evaluations spread out
over a large timeframe. Furthermore, subjects in study were
enrolled from an outpatient clinic, and could therefore be
characterized by more complex health needs compared to the
general DS population. As a consequence, the sample can’t be
considered to be representative of the population with DS and the
results should be interpreted in the light of the small sample size
and the possible selection bias. Finally, although InterRAI-ID is
validated both for in person and on the phone administration, the
different routes of administration pre- and post-lockdown could
have introduced further bias.
CONCLUSION
Despite the undoubtful importance of the lockdown in order
to reduce the spreading of the COVID-19 pandemic, the
related social isolation measures seemed to exacerbate depressive
symptoms and some functional impairment in a population of
adults with DS. Instead, aggressive behavior was less incident
and could be related to the increase of negative and depressive
symptoms. In light of such evidence, it will be important to assess
in future studies the possible presence of long-term effects on the
health of individuals with DS and how the disruptions of their
routine affected not only other individuals with ID but also their
caregivers. Doing this could lead to more awareness and to a
novel insights in possible assistance and treatment strategies.
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